Akers, A.L., Ball, K.L., Clancy, M., Comi, A.M., Faughnan, M.E., Gopal-Srivastava, R., Jacobs, T.P., Kim, H., Krischer, J., Marchuk, D.A., McCulloch, C.E., Morrison, L., Moses, M., Moy, C., Pawlokowska, L. and Young, W.L. (2013) Brain Vascular Malformation Consortium: Overview, Progress and Future Directions. Journal of Rare Disorders, 1, 5.

has been cited by the following article:

• TITLE: Subjective Cognitive Concerns and Attitudes toward Genetic Testing Are Associated with Depressive Symptoms and Quality of Life after Genetic Testing for the Cerebral Cavernous Malformation Common Hispanic Mutation (CCM1)

  AUTHORS: Richard Campbell, Christine L. Petranovich, Savannah Cheek, Leslie Morrison, Blaine Hart

  KEYWORDS: Quality of Life, Depression, Genetic Testing, Subjective Cognitive Concerns

  JOURNAL NAME: Journal of Behavioral and Brain Science, Vol.10 No.2, February 25, 2020

  ABSTRACT: Purpose: This study aimed to characterize mood and quality of life and to examine the associations of these areas with subjective cognitive concerns and attitudes toward genetic testing for the Common Hispanic Mutation, a gene that has been associated with increased risk for CCM1. Method: Fifty-four adults with previous genetic testing for the Common Hispanic Mutation completed a mail survey that included assessments of the above identified areas. Results: Self-reported depressive symptoms and quality of life did not differ between those with positive and negative genetic test results. The negative group expressed a more favorable attitude toward genetic testing (p p = 0.06). Using generalized linear regression, more subjective cognitive concerns were associated with poorer quality of life and more depressive symptoms (p p Conclusions: Subjective cognitive concerns and negative attitudes toward genetic testing may influence emotional well-being after genetic testing for the Common Hispanic Mutation. Additional research is needed that uses objective neuropsychological measures to understand the associations of subjective cognitive concerns, emotional well-being, and cognitive test performance in individuals with CCM1. There is also a need for research that focuses on protective factors and resiliency following genetic testing for CCM1 and the development of mental health interventions to preempt psychosocial difficulties.